Jackson Alan C, Scott Courtney A, Owen James, Weli Simon C, Rossiter John P
Department of Medicine (Neurology), Centre for Neuroscience Studies, Queen's University, and Kingston General Hospital, Connell 725, 76 Stuart Street, Kingston, ON, Canada K7L 2V7.
J Virol. 2007 Jun;81(12):6248-53. doi: 10.1128/JVI.00323-07. Epub 2007 Apr 4.
Minocycline is a tetracycline derivative with antiapoptotic and anti-inflammatory properties, and the drug has been shown to have beneficial effects in a variety of models of neurological disorders. The potentially neuroprotective role of minocycline was assessed in experimental in vitro and in vivo models of rabies virus infection. In this study, 5 nM minocycline did not improve the viability of embryonic mouse cortical and hippocampal neurons infected in vitro with the attenuated SAD-D29 strain of rabies virus, based on assessments using trypan blue exclusion. Two-day-old ICR mice were inoculated in the right hind limb thigh muscle with SAD-D29, and they received daily subcutaneous injections of either 50 mg/kg minocycline or vehicle (phosphate-buffered saline). Infected minocycline-treated mice experienced an earlier onset of neurologic signs and greater mortality (83% versus 50%) than those receiving vehicle (log rank test, P=0.002 and P=0.003, respectively). Immunohistochemical analysis of rabies virus antigen distribution was performed at early time points and in moribund mice. There were greater numbers of infected neurons in the regional brain areas of minocycline-treated mice than in vehicle-treated mice, which was significant in the CA1 region of the hippocampus. There was less apoptosis (P=0.01) and caspase 3 immunostaining (P=0.0008) in the midbrains of mice treated with minocycline than in mice treated with vehicle, consistent with a neuroprotective role of neuronal apoptosis that may have had a mild effect of inhibiting viral spread. Reduced infiltration of CD3+ T cells was observed in the pons/medulla of moribund mice that received minocycline therapy (P=0.008), suggesting that the anti-inflammatory actions of minocycline may intensify the neurologic disease. These findings indicate that minocycline has important detrimental effects in the therapy of experimental rabies. Empirical therapy with minocycline should therefore be approached with caution in cases of human rabies and possibly other viral encephalitides until more experimental data become available.
米诺环素是一种具有抗凋亡和抗炎特性的四环素衍生物,该药物已被证明在多种神经疾病模型中具有有益作用。在狂犬病病毒感染的体外和体内实验模型中评估了米诺环素潜在的神经保护作用。在本研究中,基于台盼蓝排斥试验评估,5 nM米诺环素并不能提高体外感染狂犬病病毒减毒株SAD-D29的胚胎小鼠皮质和海马神经元的活力。将2日龄的ICR小鼠右后肢大腿肌肉接种SAD-D29,然后每天皮下注射50 mg/kg米诺环素或赋形剂(磷酸盐缓冲盐水)。与接受赋形剂的小鼠相比,感染米诺环素治疗的小鼠出现神经症状的时间更早,死亡率更高(分别为83%对50%;对数秩检验,P = 0.002和P = 0.003)。在早期时间点和濒死小鼠中进行了狂犬病病毒抗原分布的免疫组织化学分析。与赋形剂治疗的小鼠相比,米诺环素治疗的小鼠脑区感染神经元数量更多,在海马CA1区尤为显著。与赋形剂治疗的小鼠相比,米诺环素治疗的小鼠中脑的细胞凋亡(P = 0.01)和半胱天冬酶3免疫染色(P = 0.0008)较少,这与神经元凋亡的神经保护作用一致,这种作用可能对抑制病毒传播有轻微影响。在接受米诺环素治疗的濒死小鼠的脑桥/延髓中观察到CD3+ T细胞浸润减少(P = 0.008),这表明米诺环素的抗炎作用可能会加重神经疾病。这些发现表明米诺环素在实验性狂犬病治疗中具有重要的有害作用。因此,在人类狂犬病以及可能的其他病毒性脑炎病例中,在获得更多实验数据之前,应谨慎采用米诺环素进行经验性治疗。